Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 14.71 M13.98 M16.02 M15.5 M13.82 M16.08 M 61.43 M Research & development —————— — Operating income 107.04 M82.69 M80.3 M72.69 M101.03 M84.77 M 338.78 M Non-Operating Income, Total 2.2 M2.3 M2.75 M2.27 M2.42 M2.4 M 9.84 M Interest expense, net of interest capitalized 27.15 M26 M26.27 M24.42 M23.34 M20.83 M 94.86 M Non-Operating Income, excl. Interest Expenses -24.95 M-23.7 M-23.52 M-22.16 M-20.92 M-18.43 M -85.02 M Unusual income/expense —————— — Pretax income 59.96 M40.39 M37.76 M27.59 M55.38 M42.55 M 163.29 M Equity in earnings —————— — Taxes 12.69 M8.91 M8.02 M4.77 M12.82 M9.68 M 35.29 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 47.27 M31.48 M29.74 M22.82 M42.57 M32.87 M 128 M Discontinued operations —————— — Net income 47.27 M31.48 M29.74 M22.82 M42.57 M32.87 M 128 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 47.23 M31.46 M29.72 M22.8 M42.55 M32.85 M 127.92 M Basic earnings per share (Basic EPS) 4.633.082.921.172.171.69 6.56 Diluted earnings per share (Diluted EPS) 2.391.591.51.32.171.68 6.84 Average basic shares outstanding 19.71 M19.72 M19.73 M17.59 M17.65 M17.68 M — Diluted shares outstanding 19.8 M19.78 M19.79 M17.59 M17.65 M17.68 M — EBITDA 106.78 M83.1 M80.78 M73.21 M101.52 M85.26 M 340.77 M EBIT 107.04 M82.69 M80.3 M72.69 M101.03 M84.77 M 338.78 M Cost of revenue 18.09 M2.23 M2.5 M10.6 M10.28 M5.65 M 29.03 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) -264 K412 K479 K525 K495 K495 K 1.99 M